Cumberland Pharmaceuticals To Acquire VIBATIV(R)

FDA approved injectable anti-infective with life-saving potential NASHVILLE, Tenn., Nov. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it has entered into a definitive agreement... Biopharmaceuticals, Acquisitions Cumberland Pharmaceuticals, Theravance Biopharma, VIBATIV, telavancin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news